Objective: To identify factors associated with complications necessitating unplanned removal of peripherally inserted central venous catheters (PICCs) in neonates.
Introduction
Infants often require central venous catheters to avert repeated venipunctures when intravascular access is indicated for medications and parenteral nutrition. Peripherally inserted central venous catheters (PICCs) are popular in the newborn intensive care units (NICUs) because they are 'relatively non-invasive' and can be maintained for extended periods. 1 However, complications such as occlusion, phlebitis, infection, accidental dislodgement, extravasation and leakage of fluid at catheter junctions proximal to the site of insertion occur with PICCs. [2] [3] [4] [5] [6] The identification of factors that are associated with these complications is important for patient safety and as quality improvement initiatives.
In order to minimize complications, thereby optimizing the usability of the catheter, heparin is routinely added to fluids infused through PICCs. Although this practice is widespread, its clinical utility is controversial. [3] [4] [5] [6] [7] [8] Heparin is listed as a 'high-alert' medication by the Institute for Safe Medication Practices because of a heightened risk of significant patient harm when used in error. 9 This is underscored by reports of adverse events from heparin in the neonatal period including heparin-induced thrombocytopenia, thrombosis, allergic reactions, drug incompatibility, iatrogenic intracranial hemorrhages in very low-birthweight (birthweight <1500 g) infants, 10, 11 increased risk of candidemia 12 and failed response to indomethacin therapy for patent ductus arteriosus. 13 In addition, there have been reports of fatalities associated with overdoses of heparin in neonates. 9, 14 In contrast, there is paucity of conclusive evidence validating the efficacy and clinical utility of adding heparin to infusions in neonates.
Prior to 2008, heparin was added routinely to all infusions through PICCs in our NICU. The duration of the use of PICCs in our unit was comparable to the duration reported in a clinical trial in which heparin was omitted from infusions through PICCs. 5 We hypothesized that the removal of heparin from continuous infusions through PICCs would have minimal impact on the incidence of catheter-associated complications and on the duration of the use of PICCs. This hypothesis was tested in a prospective assessment of PICC infusions without heparin. Herein, we report a comparison of the complications and the duration of the use of PICCs placed prior to and in the era in which heparin was omitted from continuous infusions. In addition, we identified factors associated with complications necessitating unplanned catheter removal.
Methods

Study setting and design
This before-and-after comparison was conducted in the NICU at the University Hospital, Cincinnati, Ohio. The policy before November 2008 was to add heparin to all continuous infusions through PICCs at dosages of 0.25 units ml À1 for volumes greater than 100 ml kg À1 per day (at least 1 unit kg À1 per h for 101 ml kg À1 per day) or 0.5 units ml À1 for infusions less than or equal to 100 ml kg À1 per day (0.5 to 2 units kg À1 per h for rates of 24 to 100 ml kg À1 per day). In November 2008, as part of a quality improvement initiative and to assess the utility of heparin, this policy was modified to omit heparin. Two study groups were defined: PICCs inserted between January 2007 and November 2008 that included heparin (epoch 1) and PICCs placed between December 2008 and June 2010 in which no heparin (epoch 2) was added to continuous infusions. Data were collected prospectively from 2008 to 2010 to identify factors associated with complications necessitating unplanned removal of catheters. PICCs removed within 24 h of placement were considered unsuccessful placements, and patients that were transferred or infants that expired with the catheter in situ were excluded from the analysis. This study was approved by the Institutional Review Board of The University Hospital.
PICC placement and care
PICCs are routinely inserted in infants that are predicted to require more than 3 days of intravenous therapy to meet nutrition and/or pharmacotherapy needs. Peripheral access is maintained until infants are hemodynamically stable for PICC placement and umbilical venous catheters are only placed as default in very ill neonates at the discretion of the physician.
PICC insertion and maintenance procedures as well as the personnel were unchanged between the two epochs. All PICCs were 1.9 FR size and were inserted by the designated team of three highly trained (PICC team) nurses who practiced rigorous sterile barrier precautions during insertion and were responsible for all catheter manipulations and removal. The location of the catheter tip was verified with a chest radiograph. When necessary, catheters were repositioned to achieve 'central' tip placement (the superior vena cava or inferior vena cava) or were otherwise designated as 'non-central' placement if attempts to relocate the tip were unsuccessful. The insertion site was assessed every 2 h for signs suggestive of infectious or mechanical complications. The minimal infusion rate was 1 ml h À1 , and upon completion of continuous infusion therapy the catheter was 'locked' and flushed with 1 ml of heparinized (2 units ml À1 ) normal saline every 8 h. PICCs were removed within 24 h of completing intravenous therapies.
Data collection and study definitions
Demographic, perinatal and outcome data were abstracted from the comprehensive database maintained by the PICC team, including weight and age at insertion, dates of insertion and removal, site of insertion, radiographic determination of tip placement as central or non-central, and the number of catheter lumens. The sites of insertion were grouped into four classes according to the vein cannulated as follows: basilic, cephalic, saphenous and post-auricular/ temporal. Data were extracted retrospectively in the epoch 1 but were collected prospectively in the epoch 2. Catheter complications were grouped into five categories: occlusion, catheter-associated blood stream infection (CA-BSI, defined as intravenous antibiotic therapy for >5 days with or without positive blood culture, while the catheter is in situ), extravasation, leakage or other. For PICCs complicated by occlusion, the preceding flow status through the catheter was documented as either continuous or intermittent. For this study, the duration of use is defined as the catheter total dwell time, including the period after completion of intravenous therapy but before the catheter removal.
Statistical analyses
Continuous data were reported as means with standard deviations or as medians with ranges. Unadjusted epoch-related comparisons of continuous data were assessed using the t test, Wilcoxon Sum Rank test or log-Rank test, as appropriate. Differences between categorical data were tested using w 2 analysis or Fisher's Exact test, as appropriate. The relationships among factors associated with complications were evaluated using Pearson Product Moment Correlation Coefficients. To ascertain the independent relationship between factors that were associated with complications necessitating PICC removal, a multivariate logistic regression model was constructed. Clinically and biologically plausible variables associated with complications at the P<0.2 level on univariate analysis were included in the model to avoid inadvertent elimination of potentially important associations. Variables were retained in the model only if they remained significant at Pp0.05. All statistical analyses were performed with SigmaPlot 11.0 (SYSTAT, San Jose, CA, USA).
Results
PICC and infant characteristics
A total of 377 PICC placements representing 3546 patient days of indwelling venous catheters qualified for analysis over the entire study period (2006 to 2010). A total of 189 catheters were inserted during epoch 1 (2007 to 2008), the period when heparin was routinely added to continuous infusions and 188 eligible placements occurred during epoch 2 (2009 to 2010) when heparin was omitted from PICC infusions. There were no significant differences in the characteristics of infants with respect to the postnatal age, body weight or in the PICC placements between the two study epochs ( Table 1) .
Duration of use of catheters
The duration of use for the entire cohort was 9.4±6.5 days (mean ± s.d.). Although the routine addition of heparin to infusions through PICCs was intended to minimize occlusion and other complications, the median (range) PICC duration of use was not significantly different between epochs 1 and 2: 7 (2 to 51) vs 
Complications
During the entire study period, 81% of PICCs were not associated with any complication and were discontinued electively upon completion of their intended use. The median (25, 75%ile) duration of use for the 74 PICCs that were removed secondary to complications was 6 (4, 10) days, compared with 8 (6, 11) days for the 303 catheters that were electively removed, P ¼ 0.005. There was no significant difference in complication rates and the indications for unplanned removal of catheters were similar between the two epochs ( Table 2) .
Among the indications for unplanned catheter removal, occlusion was the most frequent, accounting for 44% of all complications. There was no significant difference in the incidence of occlusion between the two epochs. Most of the occlusions (91%) occurred when catheters were capped and flushed intermittently with heparinized saline. A total of eight instances of CA-BSI occurred during the entire study period, yielding a rate of 2.3 per 1000 catheter days. Only one CA-BSI was encountered during epoch 2 when heparin was omitted from PICC infusions. The distributions of blood vessels cannulated for central access were basilic (31%), cephalic (27%), saphenous (24%) and post auricular/temporal (18%) and these 'ratios' did not differ significantly between the two epochs. Placement of PICCs in the cephalic vein was associated with the highest complication rate (29.4% of insertions), whereas placement in the post-auricular/temporal was associated with the lowest rate (11.7%) of complications. The differences in complication rates between cephalic and auricular-temporal placements remained significant when analyzed as a function of catheter days (37 versus 8 complications per 1000 catheter days, respectively), P ¼ 0.01.
Pearson Product Moment Correlations among risk factors for unplanned catheter removal are presented in Table 3 . Those factors associated with complications resulting in unplanned catheter removal at P<0.2 were entered into multivariate logistic regression analysis and three factors were found to be independently associated with complications: non-central placement of the catheter tip (OR: 5.4 (95% confidence interval 2.7 to 10.5)), use of dual lumen catheter (OR: 2.1 (1.1 to 4.1)) and cephalic vein insertion site (OR: 1.9 (1.1 to 3.4). Factors associated with PICC complications in neonates B Isemann et al
Discussion
We found that the rate of complications was not impacted and the duration of use was not reduced by the omission of heparin from fluids that were infused through PICCs in neonates. The most common indication for unplanned catheter removal in this study was occlusion but this was not impacted by the removal of heparin from continuous infusions through PICCs. In addition, we identified three factors that were associated with increased risk for complications necessitating unplanned removal of PICCs: non-central placement of the catheter tip, use of dual lumen catheter and cannulation of the cephalic vein. Efforts to avert these risk factors may enhance the usability of PICCs in neonates. The utility of routinely adding heparin to fluids infused through central venous catheters in order to prevent thrombus formation and catheter occlusion, thereby prolonging catheter duration of use, is controversial. Multiple factors in addition to heparinization have been reported in previous studies to impact catheter patency. These include catheter diameter (gauge), location of catheter tip, fluid infusion rate, dwell time, length of catheter outside the skin and precipitation of calcium and phosphate salts within the tubing. [4] [5] [6] 8, 15, 16 Although the concentration of heparin used in the first epoch of this study (0.25 to 0.5 units ml À1 ) is low, the dose (0.5 to 2 units kg À1 per h) is comparable to recent reports using 'low-dose' (0.5 units kg À1 per h) heparin. 4, 5 Compared with reports by Uslu et al 4 and Shah et al, 5 however, the complication rates observed in the cohorts in both the epochs of this study were lower, and removal of heparin from continuous infusions did not result in an increased rate of occlusion or a decreased duration of use. The difference may be explained, in part, by the short-term need for intravenous access of our non-surgical neonatal population. The overall rate of occlusion was lower at our institution (8.7%) compared with their reports (18.4 and 32.6%). 4, 5 We believe that the fewer complications reported in our study are attributable to the experienced, designated PICC team and conscientious catheter insertion and maintenance procedures. However, a potential opportunity for improvement is worth highlighting. After attaining adequate volume of enteral feedings and continuous intravenous fluids are discontinued, the benefit of maintaining central venous access must be weighed against the risk posed by PICCs in those infants needing to complete intravenous medication therapies. The propensity for the majority of occlusions to occur when catheters are used intermittently is consistent with the report by Evans and Lentsch 2 and suggests that, upon completion of continuous infusion of fluids, flushing PICCs more frequently than every 8 h or consideration of an alternative antithrombotic catheter lock solution may further avert occlusion, but this speculation warrants further investigation.
While the majority of unplanned removal of PICCs in this study was provoked by occlusion, a similar number of catheters were removed secondary to the combined indications of CA-BSI, extravasation of infusions and leakage along the catheter. With respect to CA-BSI, the role of heparin is controversial. Heparin has been reported to be protective against sepsis 3 but it has also been implicated in candidemia, 12 and in enhancing biofilm colonization of catheters with Staphylococcus aureus and other microbes resulting in CA-BSI. 17 This study was not powered to assess the impact of heparin on individual category of complications because of the low event rates for CA-BSI, extravasation and leakage. However, the CA-BSI rate in the second epoch is similar to the rate reported in the pediatric intensive care units and NICUs that implemented 'CA-BSI-prevention bundles' as quality improvement initiatives. [18] [19] [20] We agree with Miller et al 18 that policies regarding insertion and maintenance of PICCs, together (1) non-central location of the catheter tip, (2) use of dual lumen catheter and (3) insertion into the cephalic vein. Centrally located PICC tips were associated with fewer complications in a report in which catheters ranging in size gauge from 2F to 5F were used in children. 16 Our results replicate this finding in the neonatal population. Second, placement of single lumen catheters was associated with fewer complications than with dual lumen catheters. While dual lumen catheters obviate the need for separate intravenous access, they require additional maintenance and intermittent flushing compared with single lumen PICCs. These additional manipulations may contribute to the increased risk for complications. Finally, catheters inserted via the cephalic vein may increase the risk for mechanical complications. Hypothetically, these catheters may migrate as a result of changes in the position of the arm from the ideal placement at the junction of the brachiocephalic and jugular veins into the axillary or jugular veins. Insertion procedures that avoid the risk factors identified in this study may optimize the use of PICCs in neonates.
The validity of the study design may be limited by the evolving changes in NICU practices during the study period that were not accounted for in the analysis. For instance, the increased proportion of centrally located catheters and decrease in the proportion of dual lumen catheters during the second epoch may reflect skills acquired by the PICC team over time. Complication rates for the second epoch may have been impacted, in part, from these limitations. In addition, the data that were abstracted retrospectively for epoch 1 may be confounded by ascertainment bias.
In conclusion, the removal of heparin from continuous infusions through PICCs in neonates with short-term intravenous access needs may avert the risks associated with exposure to this 'high-alert' medication without adversely impacting the frequency of complications or the duration of use of catheters. Practices designed to minimize complications, including meticulous insertion and maintenance procedures by a designated PICC team, may enhance the successful completion of intended intravenous therapies through single PICC insertions in neonates.
